Immunoassay instruments market is witnessing a rapid technological growth that has resulted in significant market opportunity for efficient bioanalytical platforms. Currently, market players are engaged in developing immunoassay platforms with enhanced capabilities such as broad menu of tests, higher sensitivity and specificity. Other major advances introduced to researchers include shorter turnaround times (TAT), higher productivity and easy operation thereby ensuring efficient detection and determination with accurate results. The market is witnessing significant advances in the design of immunoassay platforms shifting from conventional non-competitive assays to competitive assays that are permitting the efficient detection of small molecules such as drug pollutants and metabolites. For instance, introduction of ADVIA Centaur CP Immunoassay System by Siemens Healthcare, a mid-sized immunoassay system that provides a broad menu of tests and enhanced workflow which enables overall cost reduction and eliminate the need for multiple systems.
Although, the use of immunoassay platforms has been confined to hospitals and reference laboratories, currently, there is an increasing preference for commercial diagnostic laboratories owing to their special care and short turnaround times as compared to hospitals. Tier-1 diagnostic laboratories are currently focusing on expanding their operations in less developed areas by acquiring Tier - 2 and Tier – 3 laboratories with minimal infrastructure. This creates a strong demand for compact and portable assay platforms with high reliability and sensitivity. In addition, these platforms can run on batteries in case of power failure and can be moved in ambulances in case of emergency requirements. All these features along with high affordability are expected to provide impressive growth opportunities for immunoassay instruments market.
Chemiluminescence analyzers are the fastest growing segment owing to their high sensitivity and accuracy as compared to other assay platforms. Immunofluorescence analyzers and ELFA systems constitute other major instrument segments that provide high reliability and accuracy in detection. The use of radioimmunoassay analyzers is diminishing owing to the harmful effects of radioisotopes used in the assays. The market for immunoassay instruments is influenced by consistent product modifications such as use of efficient assay substrates, and low cost light sources.
Immunoassays aid in the detection of several analytes and diagnosis of several infectious diseases. Growing preference for personalized medicine (a medical model focusing on development of patient specific therapeutics), will further enhance the scope of growth and development of immunoassay platforms. Endocrinology, cardiology, detection of autoimmune disorders and infectious disease confirmation represent other potential applications of immunoassay platforms. The global market for immunoassay instruments market was valued at USD 13.51 billion in the year 2013 and is anticipated to reach USD 23.31 billion by 2020, growing at a CAGR of 8.1% from 2014 to 2020.
Geographical landscape elucidates the market trends based on four major geographies namely North America, Europe, Asia-Pacific and Rest of the World (RoW). North America and Europe dominated the immunoassay instruments market accounting for more than 50% of the total market. This is majorly attributed to the presence of technologically sophisticated diagnostic laboratories along with ready acceptance of novel assay technologies. In addition, these regions are characterized by the presence of major market players operating in immunoassay instruments market. Asia-Pacific and RoW regions are anticipated to record highest growth rates owing to increasing demand for immunoassay platforms and rising incidences of several disorders (infectious, endocrine, etc.). In addition, these regions provide lucrative growth prospects due to huge patient population and unexplored areas of medical research as compared to North America and European countries that indicate a mature market for immunoassay instruments.
The overall immunoassay instruments market is consolidated characterized by the presence of few established players accounting for more than 50% of the total market share. Roche Diagnostics, Siemens Healthcare, Beckman Coulter, bioMerieux and Ortho Clinical Diagnostics are some of the key players operating in this market. Rigorous research investments coupled with operational expansion in emerging economies by majority of the market players are evident for promising growth prospects in this market. The factors that influence the proliferation of market are perennial product amendments followed by increasing patient population worldwide. On the other hand, high cost of the immunoassay procedures followed by unfavorable reimbursement policies might impede the market growth.
Immunoassay is a laboratory-based diagnostic procedure performed using an immunological reaction of antibodies. Immunoassay instruments measure the formation of antibody-antigen complexes in blood samples or other body fluids and are commonly employed to detect analytes in qualitative (positive/negative) or quantitative manner. An example of qualitative analysis of immunoassay test include immunoassay test for pregnancy by detecting human chorionic gonadotropin (hCG) in urine samples. Immunoassay tests now-a-days are exploring new avenues of applications in diagnosing infectious diseases, toxicology testing, detection of cancer biomarkers and other drug monitoring tests. Immunoassay techniques are especially suited for analyzing compounds that are present in extremely low concentration (nanogram to picogram) and without any prior treatments to enhance its detection.
Several common technologies that are employed by immunoassays include enzyme-linked immunosorbent assay (ELISA), immunofluorescence, radioimmunoassay, chemiluminescent immunoassay, enzyme linked fluorescence and other similar techniques. Global immunoassay instruments market is analyzed on the basis of products and application. The product market is sub-segmented into six major categories namely Chemiluminescence (CLI) Analyzers, Immuno Fluorescence (IFA) Analyzers, Enzyme Immunoassay Instruments, Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescence (ELFA) Analyzers and Multiplexed Assay Systems.
The market by applications is sub-categorized into seven types that are oncology, endocrinology, infectious disease testing, therapeutic drug monitoring, cardiology, autoimmune disorders and drugs of abuse testing. A detailed analysis and forecast for all segments in immunoassay instruments market has been provided in this study, in terms of market revenue (USD million) for the period 2012 to 2020. The report also provides the compounded annual growth rate (CAGR %) for each product and application for the forecast period from 2014 to 2020, while market size estimations have been made considering 2012 and 2013 as the base years.
In terms of the geographical distribution, the global immunoassay instruments market has been segmented into four geographies of North America, Europe, Asia-Pacific and Rest of the World. The current and future market estimations (in terms of USD million) of the above regional markets have been provided in the report for the period 2012 to 2020 with their respective growth rate (%) for the period 2014 to 2020.
The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and flourish in the global immunoassay instruments market. A PESTLE analysis has also been considered while estimating the market for individual geographies in order to provide current as well as future status. Parallel to this, the report on global immunoassay instruments market also gives regulatory scenario of the major markets in the world. The report includes announcements and guidelines by important bodies such as FDA and CE mark, along with products approved by these regulatory bodies being also mentioned in the report. The event impact analysis in the immunoassay instruments market report explains the cascading effect of major market activities with respect to immunoassay instruments or techniques. Furthermore, a qualitative analysis of usage of immunoassay instruments market by end users has been provided.
The market overview section of the report demonstrates the market dynamics and market trends such as the drivers, restraints and opportunities that influence the current and future trends of this industry. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report in order to give a thorough analysis of the overall competitive scenario in the global immunoassay instruments market.
The competitive landscape section of the report includes market share analysis of the major players in Immunoassay Instruments market. This report concludes the company profiles section which covers key information such as financial overview, product portfolio, business strategies and recent key developments about the major players in the market of immunoassay instruments market. Some of the key players profiled in this report include Abbott Laboratories, bioMerieux, DiaSorin S.p.A, Siemens Healthcare, Roche Diagnostics, Thermo Fisher Scientific, among other prominent players in the market.
The global Immunoassay Instruments market is segmented into the following categories:
Immunoassay Instruments Market, by Product Type
- Chemiluminescence (CLI) Analyzers
- Immuno Fluorescence (IFA) Analyzers
- Enzyme Immunoassay Instruments
- Radioimmunoassay Analyzers
- Enzyme Linked Fluorescent Systems
- Multiplexed Assay Systems
Immunoassay Instruments Market, by Application
- Infectious Diseases
- Therapeutic Drug Monitoring
- Autoimmune Diseases
- Drugs of Abuse
Immunoassay Instruments Market, by Geography
- North America
- Rest of the World (RoW)